Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Karl

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Frontiers in Behavioral Neuroscience|August 23, 2013
Neuregulin 1: a prime candidate for research into gene-environment interactions in schizophrenia? Insights from genetic rodent modelsTim Karl
Frontiers in Pharmacology|February 21, 2017
<i>In vivo</i> Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's DiseaseGeorgia Watt, Tim Karl
Peptides|January 2, 2007
Behavioral profiling of NPY in aggression and neuropsychiatric diseasesTim Karl, Herbert Herzog
Pharmacology, Biochemistry, and Behavior|October 31, 2020
Cannabidiol (CBD) reduces cocaine-environment memory in miceRose Chesworth, Tim Karl
Frontiers in Behavioral Neuroscience|January 8, 2015
Schizophrenia: a consequence of gene-environment interactions?Tim Karl, Jonathon C Arnold
Frontiers in Cellular Neuroscience|March 1, 2013
What does a mouse tell us about neuregulin 1-cannabis interactions?Tim Karl, Jonathon C Arnold
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentCarla Lucia Wahlich, Tim Karl
Behavioural Pharmacology|July 30, 2016
The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer's diseaseTim Karl, Brett Garner, David Cheng
Behavioural Brain Research|August 28, 2023
Light phase does not affect operant sucrose self-administration in adult male C57BL/6JAbr miceGeorgia Watt, Tim Karl, Rose Chesworth
Biochemical Society Transactions|October 31, 2015
Understanding the function of ABCA7 in Alzheimer's diseaseHongyun Li, Tim Karl, Brett Garner
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Frontiers in Behavioral Neuroscience|August 23, 2013
Neuregulin 1: a prime candidate for research into gene-environment interactions in schizophrenia? Insights from genetic rodent modelsTim Karl
Frontiers in Pharmacology|February 21, 2017
<i>In vivo</i> Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's DiseaseGeorgia Watt, Tim Karl
Peptides|January 2, 2007
Behavioral profiling of NPY in aggression and neuropsychiatric diseasesTim Karl, Herbert Herzog
Pharmacology, Biochemistry, and Behavior|October 31, 2020
Cannabidiol (CBD) reduces cocaine-environment memory in miceRose Chesworth, Tim Karl
Frontiers in Behavioral Neuroscience|January 8, 2015
Schizophrenia: a consequence of gene-environment interactions?Tim Karl, Jonathon C Arnold
Frontiers in Cellular Neuroscience|March 1, 2013
What does a mouse tell us about neuregulin 1-cannabis interactions?Tim Karl, Jonathon C Arnold
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentCarla Lucia Wahlich, Tim Karl
Behavioural Pharmacology|July 30, 2016
The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer's diseaseTim Karl, Brett Garner, David Cheng
Behavioural Brain Research|August 28, 2023
Light phase does not affect operant sucrose self-administration in adult male C57BL/6JAbr miceGeorgia Watt, Tim Karl, Rose Chesworth
Biochemical Society Transactions|October 31, 2015
Understanding the function of ABCA7 in Alzheimer's diseaseHongyun Li, Tim Karl, Brett Garner
Pageof 13